Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Colonic Polyps 2Breast Neoplasms 2Rectal Diseases 1Prostatic Neoplasms 1Pneumoperitoneum 1Pancreatic Neoplasms 1Pain, Postoperative 1Lung Cancer Metastatic 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastric Subepithelial Tumor 1Erectile Dysfunction 1Endometriosis 1Diverticulitis 1Crohn Disease 1Constipation 1Colorectal Neoplasms 1Colonic Diseases 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Bites and Stings 1Bile Duct Neoplasms 1Agnosia 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Surgical Instruments × Clear all
NCT06294574 2025-09-22

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

University of Alabama at Birmingham

Phase NA Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT05173415 2025-02-24

MALLORCA

Brust-Zentrum AG

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡